Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Change in Inventory: 2022-2025

Historic Change in Inventory for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to -$70,366.

  • InMed Pharmaceuticals' Change in Inventory fell 190.16% to -$70,366 in Q3 2025 from the same period last year, while for Sep 2025 it was -$329,266, marking a year-over-year decrease of 209.81%. This contributed to the annual value of -$283,151 for FY2025, which is 327.59% down from last year.
  • As of Q3 2025, InMed Pharmaceuticals' Change in Inventory stood at -$70,366, which was down 147.80% from $147,203 recorded in Q2 2025.
  • In the past 5 years, InMed Pharmaceuticals' Change in Inventory registered a high of $1.1 million during Q2 2022, and its lowest value of -$390,329 during Q3 2023.
  • In the last 3 years, InMed Pharmaceuticals' Change in Inventory had a median value of -$70,366 in 2025 and averaged -$62,247.
  • As far as peak fluctuations go, InMed Pharmaceuticals' Change in Inventory spiked by 399.09% in 2024, and later plummeted by 190.16% in 2025.
  • Quarterly analysis of 4 years shows InMed Pharmaceuticals' Change in Inventory stood at -$165,017 in 2022, then plummeted by 31.98% to -$217,784 in 2023, then spiked by 46.41% to -$116,717 in 2024, then plummeted by 190.16% to -$70,366 in 2025.
  • Its last three reported values are -$70,366 in Q3 2025, $147,203 for Q2 2025, and -$289,386 during Q1 2025.